These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. One hundred and thirty-seven living donor pediatric liver transplants at Riyadh Military Hospital. Results and outlook for future. Khan I; Al-Shaqrani MA; Arain ZB; Al-Hebbi HA; Wali SH; Bassas AF Saudi Med J; 2009 Mar; 30(3):403-8. PubMed ID: 19271071 [TBL] [Abstract][Full Text] [Related]
64. Long-term follow-up of donor chimerism and tolerance after human liver transplantation. Ayala R; Grande S; Albizua E; Crooke A; Meneu JC; Moreno A; Pérez B; Gilsanz F; Moreno E; Martínez-Lopez J Liver Transpl; 2009 Jun; 15(6):581-91. PubMed ID: 19479801 [TBL] [Abstract][Full Text] [Related]
65. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients. Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918 [TBL] [Abstract][Full Text] [Related]
66. Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection. Huskey J; Gralla J; Wiseman AC Clin J Am Soc Nephrol; 2011 Feb; 6(2):423-9. PubMed ID: 21088287 [TBL] [Abstract][Full Text] [Related]
67. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study. Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932 [TBL] [Abstract][Full Text] [Related]
68. Immunosuppressive activity of serum taken from a liver transplant recipient after withdrawal of immunosuppressants. Hsu LW; Goto S; Nakano T; Lai CY; Lin YC; Kao YH; Chen SH; Cheng YF; Jawan B; Chiu KW; Chen CL Transpl Immunol; 2007 Feb; 17(2):137-46. PubMed ID: 17306745 [TBL] [Abstract][Full Text] [Related]
69. Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection. Husain S; Raza K; Pilewski JM; Zaldonis D; Crespo M; Toyoda Y; Shutt K; Spichty K; Bentlejewski C; Pakstis DL; Carey ME; McCurry KR; Zeevi A Transplantation; 2009 Jun; 87(12):1852-7. PubMed ID: 19543064 [TBL] [Abstract][Full Text] [Related]
70. How can we measure immunologic tolerance in humans? Najafian N; Albin MJ; Newell KA J Am Soc Nephrol; 2006 Oct; 17(10):2652-63. PubMed ID: 16928808 [TBL] [Abstract][Full Text] [Related]
71. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging. Miloh T; Annunziato R; Arnon R; Warshaw J; Parkar S; Suchy FJ; Iyer K; Kerkar N Pediatrics; 2009 Nov; 124(5):e844-50. PubMed ID: 19822583 [TBL] [Abstract][Full Text] [Related]
73. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005 [TBL] [Abstract][Full Text] [Related]
74. Biomarkers of the immunomodulatory effect of immunosuppressive drugs in transplant recipients. Millán O; Urtasun N; Brunet M Transplant Rev (Orlando); 2009 Apr; 23(2):120-8. PubMed ID: 19298943 [TBL] [Abstract][Full Text] [Related]
75. Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis. Ling X; Xiong J; Liang W; Schroder PM; Wu L; Ju W; Kong Y; Shang Y; Guo Z; He X Transplantation; 2012 Apr; 93(7):737-43. PubMed ID: 22357178 [TBL] [Abstract][Full Text] [Related]
76. Studies of Pediatric Liver Transplantation: 2002 update. An overview of demographics, indications, timing, and immunosuppressive practices in pediatric liver transplantation in the United States and Canada. McDiarmid SV; Anand R; Lindblad AS; Pediatr Transplant; 2004 Jun; 8(3):284-94. PubMed ID: 15176967 [TBL] [Abstract][Full Text] [Related]
77. Mucormycosis in a liver allograft: salvage re-transplantation and targeted immunosuppressive management. Gurevich M; Levi I; Steinberg R; Shonfeld T; Shapiro R; Israeli M; Sprecher H; Shalit I; Mor E Transpl Infect Dis; 2012 Oct; 14(5):E97-101. PubMed ID: 22897560 [TBL] [Abstract][Full Text] [Related]